Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Combined With Butorphanol for Pain After Lobectomy
NCT06398834Phase 4Completed
- Sponsor
- Hefei Second People's Hospital
- Start
- Mar 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in post-thoracotomy pain syndrome (PTPS) (2 arms), sponsored by Hefei Second People's Hospital. Primary endpoint: Incidence of chronic pain. Started Mar 2022; status: completed.
02
Drugs
esketamine
03
Conditions
post-thoracotomy pain syndrome (PTPS)
Beyond the preview
Go deeper on NCT06398834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06398834.